Promising Results In Medical Cannabis: CannaMore’s Successful Phase 2a Trial For Colitis Treatment
Medical marijuana keeps showing positive results in treating various pathologies. CannaMore Biotechs, an Israel-based clinical-stage company, announced the successful completion of its Phase 2a clinical trial, which evaluated the safety and efficacy of a CBD-based enema formulation to treat patients with Ulcerative Colitis (UC).
What Happened?
The open-label, single-arm study, conducted over three months, involved ten patients. The goal was to assess the safety, tolerability and efficacy of IcBD-01, which is a CBD-based treatment for ulcerative colitis. The results were promising, with significant improvements in disease severity and patient-reported symptoms.
Why It Matters
The study achieved its primary endpoint, showing a reduction …